Found: 21
Select item for more details and to access through your institution.
Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot Study.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 4, p. 240, doi. 10.3390/jpm11040240
- By:
- Publication type:
- Article
Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis.
- Published in:
- Current Allergy & Asthma Reports, 2015, v. 15, n. 12, p. 1, doi. 10.1007/s11882-015-0569-2
- By:
- Publication type:
- Article
Comparative effects of weight loss and incretin‐based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 570, doi. 10.1111/dom.14903
- By:
- Publication type:
- Article
Longitudinal progression of aspirin‐exacerbated respiratory disease: analysis of a national insurance claims database.
- Published in:
- International Forum of Allergy & Rhinology, 2019, v. 9, n. 12, p. 1420, doi. 10.1002/alr.22412
- By:
- Publication type:
- Article
Treatment practices for aspirin‐exacerbated respiratory disease: analysis of a national insurance claims database.
- Published in:
- International Forum of Allergy & Rhinology, 2020, v. 10, n. 2, p. 190, doi. 10.1002/alr.22471
- By:
- Publication type:
- Article
Reply to Li et al.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 Diabetes.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 10, p. 1088, doi. 10.1164/rccm.202303-0491OC
- By:
- Publication type:
- Article
Reply to Watchorn : Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impaired E Prostanoid<sub>2</sub> Expression and Resistance to Prostaglandin E<sub>2</sub> in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2016, v. 54, n. 1, p. 34, doi. 10.1165/rcmb.2014-0486OC
- By:
- Publication type:
- Article
Impaired EP<sub>2</sub> expression causes resistance to prostaglandin E<sub>2</sub> in nasal polyp fibroblasts from subjects with AERD.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2016, v. 54, n. 1, p. E1, doi. 10.1165/rcmb.2014-0486oc
- By:
- Publication type:
- Article
Liraglutide as a Prophylactic Treatment for Sepsis Induced Lung Inflammation and Edema.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.L7447
- By:
- Publication type:
- Article
DrugWAS: Drug‐wide Association Studies for COVID‐19 Drug Repurposing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 6, p. 1537, doi. 10.1002/cpt.2376
- By:
- Publication type:
- Article
Exploration of an alternative to body mass index to characterize the relationship between height and weight for prediction of metabolic phenotypes and cardiovascular outcomes.
- Published in:
- Obesity Science & Practice, 2022, v. 8, n. 1, p. 124, doi. 10.1002/osp4.543
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonist use is associated with lower serum periostin.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 4, p. 469, doi. 10.1111/cea.14284
- By:
- Publication type:
- Article
Dual GIPR and GLP‐1R agonist tirzepatide inhibits aeroallergen‐induced allergic airway inflammation in mouse model of obese asthma.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 216, doi. 10.1111/cea.14252
- By:
- Publication type:
- Article
Objective validity of patient‐reported symptoms in aspirin‐exacerbated respiratory disease patients.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 2, p. 348, doi. 10.1111/cea.14062
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonist inhibits aeroallergen‐induced activation of ILC2 and neutrophilic airway inflammation in obese mice.
- Published in:
- Allergy, 2021, v. 76, n. 11, p. 3433, doi. 10.1111/all.14879
- By:
- Publication type:
- Article
Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 1, p. 71, doi. 10.1007/s41030-022-00211-x
- By:
- Publication type:
- Article
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.
- Published in:
- 2021
- By:
- Publication type:
- Letter